{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:13:54Z","timestamp":1778674434062,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2021YFA1201200"],"award-info":[{"award-number":["2021YFA1201200"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172083"],"award-info":[{"award-number":["82172083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Reprogramming tumor-associated macrophages (TAMs) from the pro-tumoral M2-like state to the immunostimulatory M1-like phenotype has emerged as a promising strategy for tumor therapy. However, most M2-like TAMs are preferentially located in hypoxic regions of the tumor, which are poorly accessible to many advanced drug delivery systems, posing a significant challenge to effective TAM reprogramming. Here, leveraging the tropism of facultative anaerobic bacteria to localize and propagate in the hypoxic tumor, an optogenetically engineered\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    Nissle 1917 strain conjugated with murine STING agonist (EcN\n                    <jats:sub>flaB<\/jats:sub>\n                    @UPD) was developed for cancer-specific immunotherapy. Upon near-infrared light illumination, the blue and UV emissions from upconversion nanoparticles (UCNPs) simultaneously activate the expression of Toll-like receptor (TLR) agonist, flaB, from EcN\n                    <jats:sub>flaB<\/jats:sub>\n                    , and the release of photocaged murine STING agonist, DMXAA, respectively. This spatiotemporally synchronized dual release ensures co-localized STING and TLR5 agonists inside the hypoxic niche, repolarizing TAMs from the M2 to the M1 phenotype via synergistic TLR5-MAPK1-NF-\u03baB and STING-NF-\u03baB signaling. The polarization of TAMs enhances their antigen-presenting capacity and, more importantly, activates the cytotoxic, stem-like and memory CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells responses. This subsequently inhibits tumor growth, relapse, and metastasis in the murine 4T1 tumor model. Collectively, our work introduces the bacteria-based system that uses near-infrared light to dual-release immunotherapeutics for systemic anti-tumor immunity, opening new avenues for precise and effective cancer immunotherapy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-026-04300-w","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:40:13Z","timestamp":1775133613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Photoactivated probiotic micro-reactor synchronizes STING\/TLRs agonists to spatiotemporally synergize antitumor immunotherapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuzhi","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yidi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"5","key":"4300_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350.","journal-title":"Nat Med"},{"issue":"7","key":"4300_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14(7):399\u2013416.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7519","key":"4300_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V, Cyrus N, Brokowski CE, Eisenbarth SC, Phillips GM, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513(7519):559\u201363.","journal-title":"Nature"},{"issue":"10","key":"4300_CR4","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1172\/JCI84427","volume":"126","author":"AT Henze","year":"2016","unstructured":"Henze AT, Mazzone M. The impact of hypoxia on tumor-associated macrophages. J Clin Invest. 2016;126(10):3672\u20139.","journal-title":"J Clin Invest"},{"issue":"11","key":"4300_CR5","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41556-022-01002-x","volume":"24","author":"KC Kao","year":"2022","unstructured":"Kao KC, Vilbois S, Tsai CH, Ho PC. Metabolic communication in the tumour\u2013immune microenvironment. Nat Cell Biol. 2022;24(11):1574\u201383.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"4300_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han FF, Du Y, Shi HQ, Zhou W. Hypoxic microenvironment in cancer: Molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):70.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4300_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrc1893","volume":"6","author":"AI Minchinton","year":"2006","unstructured":"Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6(8):583\u201392.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"4300_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","volume":"18","author":"SB Zhou","year":"2018","unstructured":"Zhou SB, Gravekamp C, Bermudes D, Liu K. Tumour-targeting bacteria engineered to fight cancer. Nat Rev Cancer. 2018;18(12):727\u201343.","journal-title":"Nat Rev Cancer"},{"issue":"6667","key":"4300_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.add7034","volume":"382","author":"RL Vincent","year":"2023","unstructured":"Vincent RL, Gurbatri CR, Li FD, Vardoshvili A, Coker C, Im J, Ballister ER, Rouanne M, Savage T, de los Santos-, Alexis K, et al. Probiotic-guided CAR-T cells for solid tumor targeting. Science. 2023;382(6667):211\u20138.","journal-title":"Science"},{"issue":"7","key":"4300_CR10","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.cell.2025.02.002","volume":"188","author":"Z Chang","year":"2025","unstructured":"Chang Z, Guo X, Li X, Wang Y, Zang Z, Pei S, Lu W, Li Y, Huang JD, Xiao Y, et al. Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization. Cell. 2025;188(7):1842\u201357.","journal-title":"Cell"},{"issue":"6622","key":"4300_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.add9667","volume":"378","author":"CR Gurbatri","year":"2022","unstructured":"Gurbatri CR, Arpaia N, Danino T. Engineering bacteria as interactive cancer therapies. Science. 2022;378(6622):858\u201363.","journal-title":"Science"},{"issue":"8038","key":"4300_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","volume":"635","author":"A Redenti","year":"2024","unstructured":"Redenti A, Im J, Redenti B, Li F, Rouanne M, Sheng Z, Sun W, Gurbatri CR, Huang S, Komaranchath M, et al. Probiotic neoantigen delivery vectors for precision cancer immunotherapy. Nature. 2024;635(8038):453\u201361.","journal-title":"Nature"},{"key":"4300_CR13","doi-asserted-by":"publisher","first-page":"115577","DOI":"10.1016\/j.addr.2025.115577","volume":"221","author":"E Totter","year":"2025","unstructured":"Totter E, von Einsiedel E, Regazzoni L, Schuerle S. Paving the way for bacteria-based drug delivery: Biohybrid microrobots emerging from microrobotics and synthetic biology. Adv Drug Deliv Rev. 2025;221:115577.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"4300_CR14","doi-asserted-by":"publisher","first-page":"101512","DOI":"10.1016\/j.xcrm.2024.101512","volume":"5","author":"YZ Yang","year":"2024","unstructured":"Yang YZ, Wang YY, Zeng FY, Chen YH, Chen ZY, Yan F. Ultrasound-visible engineered bacteria for tumor chemo-immunotherapy. Cell Rep Med. 2024;5(5):101512.","journal-title":"Cell Rep Med"},{"key":"4300_CR15","first-page":"1","volume":"31","author":"ZC Liu","year":"2025","unstructured":"Liu ZC, Lei LL, Zhang ZN, Du M, Chen ZY. Ultrasound-responsive engineered bacteria mediated specific controlled expression of catalase and efficient radiotherapy. Mater Today Bio. 2025;31:1\u20139.","journal-title":"Mater Today Bio"},{"issue":"1","key":"4300_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41551-021-00772-3","volume":"6","author":"T Chien","year":"2022","unstructured":"Chien T, Harimoto T, Kepecs B, Gray K, Coker C, Hou N, Pu K, Azad T, Nolasco A, Pavlicova M, et al. Enhancing the tropism of bacteria via genetically programmed biosensors. Nat Biomed Eng. 2022;6(1):94\u2013104.","journal-title":"Nat Biomed Eng"},{"issue":"30","key":"4300_CR17","doi-asserted-by":"publisher","first-page":"2404901","DOI":"10.1002\/adma.202404901","volume":"36","author":"FY Li","year":"2024","unstructured":"Li FY, Zhu PP, Zheng BZ, Lu ZJ, Fang C, Fu YK, Li X. A customized biohybrid presenting cascade responses to tumor microenvironment. Adv Mater. 2024;36(30):2404901.","journal-title":"Adv Mater"},{"issue":"1","key":"4300_CR18","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/s41467-023-37225-1","volume":"14","author":"XT Ma","year":"2023","unstructured":"Ma XT, Liang XL, Li Y, Feng QQ, Cheng KM, Ma NN, Zhu F, Guo XJ, Yue YL, Liu GN, et al. Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field. Nat Commun. 2023;14(1):1606.","journal-title":"Nat Commun"},{"issue":"1","key":"4300_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00253-024-13378-x","volume":"109","author":"ZY Liu","year":"2025","unstructured":"Liu ZY, Wang LT, Wu PY, Yuan LJ. Precision tumor treatment utilizing bacteria: Principles and future perspectives. Appl Microbiol Biotechnol. 2025;109(1):1\u201318.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"10","key":"4300_CR20","doi-asserted-by":"publisher","first-page":"9485","DOI":"10.1126\/sciadv.adk9485","volume":"10","author":"M Chen","year":"2024","unstructured":"Chen M, Han QJ, Zhang MM, Liu Y, Wang L, Yang FM, Li Q, Cao ZP, Fan CH, Liu JY. Upconversion dual-photosensitizer-expressing bacteria for Near-Infrared monochromatically excitable synergistic phototherapy. Sci Adv. 2024;10(10):9485.","journal-title":"Sci Adv"},{"issue":"12","key":"4300_CR21","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1002\/bit.28829","volume":"121","author":"XY Liu","year":"2024","unstructured":"Liu XY, Fan YL, Zhang XY, Li LY, Yang C, Ma XY, Bai GJ, Sun DW, Wang YX, Wang JY, et al. Sequential delivery of photosensitizers and checkpoint inhibitors by engineered bacteria for enhanced cancer photodynamic immunotherapy. Biotechnol Bioeng. 2024;121(12):3881\u201392.","journal-title":"Biotechnol Bioeng"},{"issue":"3","key":"4300_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nchembio.1430","volume":"10","author":"LB Motta-Mena","year":"2014","unstructured":"Motta-Mena LB, Reade A, Mallory MJ, Glantz S, Weiner OD, Lynch KW, Gardner KH. An optogenetic gene expression system with rapid activation and deactivation kinetics. Nat Chem Biol. 2014;10(3):196\u2013202.","journal-title":"Nat Chem Biol"},{"issue":"16","key":"4300_CR23","doi-asserted-by":"publisher","first-page":"e2309295","DOI":"10.1002\/advs.202309295","volume":"11","author":"J Liu","year":"2024","unstructured":"Liu J, Yuan SC, Bremmer A, Hu QY. Convergence of nanotechnology and bacteriotherapy for biomedical applications. Adv Sci. 2024;11(16):e2309295.","journal-title":"Adv Sci"},{"issue":"5","key":"4300_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41573-024-00914-7","volume":"23","author":"Z Fralish","year":"2024","unstructured":"Fralish Z, Chen A, Khan S, Zhou P, Reker D. The landscape of small-molecule prodrugs. Nat Rev Drug Discov. 2024;23(5):365\u201380.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"4300_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrd2468","volume":"7","author":"J Rautio","year":"2008","unstructured":"Rautio J, Kumpulainen H, Heimbach T, Oliyai R, Oh D, J\u00e4rvinen T, Savolainen J. Prodrugs: Design and clinical applications. Nat Rev Drug Discov. 2008;7(3):255\u201370.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"4300_CR26","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1039\/D2CS00673A","volume":"52","author":"HH Han","year":"2023","unstructured":"Han HH, Wang HM, Jangili P, Li ML, Wu LL, Zang Y, Sedgwick AC, Li J, He XP, James TD, et al. The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy. Chem Soc Rev. 2023;52(3):879\u2013920.","journal-title":"Chem Soc Rev"},{"key":"4300_CR27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jcis.2024.09.108","volume":"678","author":"FY Chen","year":"2025","unstructured":"Chen FY, Qiu Y, Liu JL. NIR responsive nanosystem based on upconversion nanoparticle-engineered bacteria for immune\/photodynamic combined therapy with bacteria self-clearing capability. J Colloid Interface Sci. 2025;678:583\u201394.","journal-title":"J Colloid Interface Sci"},{"key":"4300_CR28","doi-asserted-by":"publisher","first-page":"101741","DOI":"10.1016\/j.progpolymsci.2023.101741","volume":"146","author":"T Liu","year":"2023","unstructured":"Liu T, Bao BK, Li YZ, Lin QN, Zhu LY. Photo-responsive polymers based on \u03bf-nitrobenzyl derivatives: From structural design to applications. Prog Polym Sci. 2023;146:101741.","journal-title":"Prog Polym Sci"},{"key":"4300_CR29","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.1182\/blood-2022-158434","volume":"140","author":"PQ Zhao","year":"2022","unstructured":"Zhao PQ, Zhou SY, Qiu LH, Li LF, Qian ZZ, Fu K, Zhang HL. Upconversion optogenetic engineered bacteria system for time-resolved imaging diagnosis and light-controlled lymphoma therapy. Blood. 2022;140:6008\u20139.","journal-title":"Blood"},{"issue":"8","key":"4300_CR30","doi-asserted-by":"publisher","first-page":"2207198","DOI":"10.1002\/adma.202207198","volume":"35","author":"XQ Zhu","year":"2023","unstructured":"Zhu XQ, Chen SH, Hu XW, Zhao LJ, Wang YQ, Huang JZ, Chen JW, Qiu YZ, Zhang XF, Wang MD, et al. Near-Infrared nano-optogenetic activation of cancer immunotherapy via engineered bacteria. Adv Mater. 2023;35(8):2207198.","journal-title":"Adv Mater"},{"issue":"7","key":"4300_CR31","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","volume":"11","author":"L Corrales","year":"2015","unstructured":"Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, Woo SR, Lemmens E, Banda T, Leong JJ, et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 2015;11(7):1018\u201330.","journal-title":"Cell Rep"},{"issue":"376","key":"4300_CR32","doi-asserted-by":"publisher","first-page":"aak9537","DOI":"10.1126\/scitranslmed.aak9537","volume":"9","author":"JH Zheng","year":"2017","unstructured":"Zheng JH, Nguyen VH, Jiang SN, Park SH, Tan W, Hong SH, Shin MG, Chung IJ, Hong Y, Bom HS, et al. Two-step enhanced cancer immunotherapy with engineered salmonella typhimurium secreting heterologous flagellin. Sci Transl Med. 2017;9(376):aak9537.","journal-title":"Sci Transl Med"},{"issue":"15","key":"4300_CR33","doi-asserted-by":"publisher","first-page":"2210440","DOI":"10.1002\/adma.202210440","volume":"35","author":"XJ Chen","year":"2023","unstructured":"Chen XJ, Tang QY, Wang JQ, Zhou Y, Li FQ, Xie YX, Wang XA, Du L, Li JR, Pu J, et al. A DNA\/DMXAA\/metal-organic framework activator of innate immunity for boosting anticancer immunity. Adv Mater. 2023;35(15):2210440.","journal-title":"Adv Mater"},{"issue":"43","key":"4300_CR34","doi-asserted-by":"publisher","first-page":"17253","DOI":"10.1073\/pnas.1308887110","volume":"110","author":"FY McWhorter","year":"2013","unstructured":"McWhorter FY, Wang T, Nguyen P, Chung T, Liu WF. Modulation of macrophage phenotype by cell shape. Proc Natl Acad Sci U S A. 2013;110(43):17253\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"4300_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/metabo10110429","volume":"10","author":"EM Palmieri","year":"2020","unstructured":"Palmieri EM, McGinity C, Wink DA, McVicar DW. Nitric oxide in macrophage immunometabolism: Hiding in plain sight. Metabolites. 2020;10(11):429.","journal-title":"Metabolites"},{"issue":"1","key":"4300_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"SZ Chen","year":"2023","unstructured":"Chen SZ, Saeed A, Liu Q, Jiang Q, Xu HZ, Xiao GG, Rao L, Duo YH. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8(1):207.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"4300_CR37","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1158\/0008-5472.CAN-15-1737","volume":"76","author":"CD Mills","year":"2016","unstructured":"Mills CD, Lenz LL, Harris RA. A breakthrough: Macrophage-directed cancer immunotherapy. Cancer Res. 2016;76(3):513\u20136.","journal-title":"Cancer Res"},{"key":"4300_CR38","doi-asserted-by":"crossref","unstructured":"Zhou JP, Zhang SL, Guo CY. Crosstalk between macrophages and natural killer cells in the tumor microenvironment. Int Immunopharmacol. 2021; 101(Pt B):108374.","DOI":"10.1016\/j.intimp.2021.108374"},{"issue":"131","key":"4300_CR39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41416-024-02715-6","volume":"131","author":"JH Rannikko","year":"2024","unstructured":"Rannikko JH, Hollm\u00e9n M. Clinical landscape of macrophage-reprogramming cancer immunotherapies. Br J Cancer. 2024;131(131):627\u201340.","journal-title":"Br J Cancer"},{"issue":"4","key":"4300_CR40","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/cbin.11528","volume":"45","author":"DY Tu","year":"2021","unstructured":"Tu DY, Dou J, Wang MK, Zhuang HW, Zhang XY. M2 macrophages contribute to cell proliferation and migration of breast cancer. Cell Biol Int. 2021;45(4):831\u20138.","journal-title":"Cell Biol Int"},{"issue":"3","key":"4300_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1470-2045(03)01018-0","volume":"4","author":"BC Baguley","year":"2003","unstructured":"Baguley BC. Antivascular therapy of cancer: DMXAA. Lancet Oncol. 2003;4(3):141\u20138.","journal-title":"Lancet Oncol"},{"issue":"4","key":"4300_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.tim.2013.01.005","volume":"21","author":"C Zhao","year":"2013","unstructured":"Zhao C, Collins MN, Hsiang TY, Krug RM. Interferon-induced ISG15 pathway: An ongoing virus-host battle. Trends Microbiol. 2013;21(4):181\u20136.","journal-title":"Trends Microbiol"},{"issue":"9","key":"4300_CR43","doi-asserted-by":"publisher","first-page":"e20210108","DOI":"10.1084\/jem.20210108","volume":"218","author":"C Mowat","year":"2021","unstructured":"Mowat C, Mosley SR, Namdar A, Schiller D, Baker K. Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN-driven CCL5 and CXCL10. J Exp Med. 2021;218(9):e20210108.","journal-title":"J Exp Med"},{"key":"4300_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molimm.2017.12.001","volume":"110","author":"RE Vatner","year":"2019","unstructured":"Vatner RE, Janssen EM. STING, DCs and the link between innate and adaptive tumor immunity. Mol Immunol. 2019;110:13\u201323.","journal-title":"Mol Immunol"},{"issue":"3","key":"4300_CR45","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrclinonc.2015.209","volume":"13","author":"MJ Smyth","year":"2016","unstructured":"Smyth MJ, Ngiow SF, Ribas A, Teng MWL. Combination cancer immunotherapies tailored to the tumour microenvironment. Nat Rev Clin Oncol. 2016;13(3):143\u201358.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"4300_CR46","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.cmet.2025.03.012","volume":"37","author":"YZ Wang","year":"2025","unstructured":"Wang YZ, Chen WH, Han ZY, Zhang SM, Ji P, Zhang C, Liang JL, Zhang XZ. Targeted tumor therapy with L-cyst(e)ine-addicted bacteria-nanodrug biohybrids. Cell Metab. 2025;37(6):1277\u2013e12931278.","journal-title":"Cell Metab"},{"issue":"12","key":"4300_CR47","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/s41563-023-01646-6","volume":"22","author":"NQ Gong","year":"2023","unstructured":"Gong NQ, Han XX, Xue LL, El-Mayta R, Metzloff AE, Billingsley MM, Hamilton AG, Mitchell MJ. In situ pegylation of CAR T cells alleviates cytokine release syndrome and neurotoxicity. Nat Mater. 2023;22(12):1571\u201380.","journal-title":"Nat Mater"},{"issue":"7735","key":"4300_CR48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-018-0774-y","volume":"564","author":"V Staedtke","year":"2018","unstructured":"Staedtke V, Bai RY, Kim K, Darvas M, Davila ML, Riggins GJ, Rothman PB, Papadopoulos N, Kinzler KW, Vogelstein B, et al. Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. Nature. 2018;564(7735):273\u20137.","journal-title":"Nature"},{"issue":"10","key":"4300_CR49","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/jth.12362","volume":"11","author":"SH Zhang","year":"2013","unstructured":"Zhang SH, Zhang Y, Shen J, Zhang S, Chen L, Gu J, Mruk JS, Cheng G, Zhu L, Kunapuli SP, et al. Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid inhibits platelet activation and thrombosis via inhibition of thromboxane A2 signaling and phosphodiesterase. J Thromb Haemost. 2013;11(10):1855\u201366.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"4300_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1309\/AJCPRHM8CZH5EMFD","volume":"143","author":"V Vanchinathan","year":"2015","unstructured":"Vanchinathan V, Mirzamani N, Kantipudi R, Schwartz EJ, Sundram UN. The vascular marker CD31 also highlights histiocytes and histiocyte-like cells within cutaneous tumors. Am J Clin Pathol. 2015;143(2):177\u201385.","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"4300_CR51","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-16-1536","volume":"77","author":"S Tohme","year":"2017","unstructured":"Tohme S, Simmons RL, Tsung A. Surgery for cancer: A trigger for metastases. Cancer Res. 2017;77(7):1548\u201352.","journal-title":"Cancer Res"},{"issue":"5","key":"4300_CR52","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1021\/acs.nanolett.3c04563","volume":"24","author":"L Tang","year":"2024","unstructured":"Tang L, Fu C, Liu HN, Yin Y, Cao YQ, Feng JW, Zhang AN, Wang W. Chemoimmunotherapeutic nanogel for pre- and postsurgical treatment of malignant melanoma by reprogramming tumor-associated macrophages. Nano Lett. 2024;24(5):1717\u201328.","journal-title":"Nano Lett"},{"issue":"8","key":"4300_CR53","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.21037\/tcr.2020.03.63","volume":"9","author":"J Soh","year":"2020","unstructured":"Soh J, Komoike Y, Mitsudomi T. Surgical therapy for pulmonary metastasis of breast cancer. Transl Cancer Res. 2020;9(8):5044\u201352.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"4300_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-022-01557-5","volume":"24","author":"C Li","year":"2022","unstructured":"Li C, Yoshimura T, Tian M, Wang Y, Kondo T, Yamamoto KI, Fujisawa M, Ohara T, Sakaguchi M, Matsukawa A. Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4T1 breast cancer. Breast Cancer Res. 2022;24(1):1\u201321.","journal-title":"Breast Cancer Res"},{"issue":"26","key":"4300_CR55","doi-asserted-by":"publisher","first-page":"22857","DOI":"10.18632\/oncotarget.3127","volume":"6","author":"M Tham","year":"2015","unstructured":"Tham M, Khoo K, Yeo KP, Kato M, Prevost-Blondel A, Angeli V, Abastado JP. Macrophage depletion reduces postsurgical tumor recurrence and metastatic growth in a spontaneous murine model of melanoma. Oncotarget. 2015;6(26):22857\u201368.","journal-title":"Oncotarget"},{"key":"4300_CR56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.ircmb.2018.07.001","volume":"342","author":"JL Guerriero","year":"2019","unstructured":"Guerriero JL, Macrophages. Their untold story in T cell activation and function. Int Rev Cell Mol Biol. 2019;342:73\u201393.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"11","key":"4300_CR57","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41568-023-00615-0","volume":"23","author":"T Gebhardt","year":"2023","unstructured":"Gebhardt T, Park SL, Parish IA. Stem-like exhausted and memory CD8+ T cells in cancer. Nat Rev Cancer. 2023;23(11):780\u201398.","journal-title":"Nat Rev Cancer"},{"key":"4300_CR58","doi-asserted-by":"publisher","first-page":"108646","DOI":"10.1016\/j.intimp.2022.108646","volume":"107","author":"B Wang","year":"2022","unstructured":"Wang B, Hu J, Zhang J, Zhao LN. Radiation therapy regulates TCF-1 to maintain CD8+ T cell stemness and promotes anti-tumor immunotherapy. Int Immunopharmacol. 2022;107:108646.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4300_CR59","doi-asserted-by":"publisher","first-page":"5653","DOI":"10.1038\/s41467-023-41438-9","volume":"14","author":"XQ Zhang","year":"2023","unstructured":"Zhang XQ, Wei ZH, Yong TY, Li SY, Bie NN, Li JY, Li X, Liu HJ, Xu H, Yan YC, et al. Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8+ T cells to boost anti-PD-1 therapy. Nat Commun. 2023;14(1):5653.","journal-title":"Nat Commun"},{"issue":"4","key":"4300_CR60","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41590-021-00878-5","volume":"22","author":"BC Duckworth","year":"2021","unstructured":"Duckworth BC, Lafouresse F, Wimmer VC, Broomfield BJ, Dalit L, Alexandre YO, Sheikh AA, Qin RZ, Alvarado C, Mielke LA, et al. Effector and stem-like memory cell fates are imprinted in distinct lymph node niches directed by CXCR3 ligands. Nat Immunol. 2021;22(4):434\u201348.","journal-title":"Nat Immunol"},{"issue":"6754","key":"4300_CR61","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, Lenig D, F\u00f6rster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401(6754):708\u201312.","journal-title":"Nature"},{"issue":"1","key":"4300_CR62","doi-asserted-by":"publisher","first-page":"9023","DOI":"10.1038\/s41467-024-53392-1","volume":"15","author":"YY Pu","year":"2024","unstructured":"Pu YY, Zhou BG, Bing JH, Wang L, Chen MQ, Shen YC, Gao S, Zhou M, Wu WC, Shi JL. Ultrasound-triggered and glycosylation inhibition-enhanced tumor piezocatalytic immunotherapy. Nat Commun. 2024;15(1):9023.","journal-title":"Nat Commun"},{"issue":"161","key":"4300_CR63","first-page":"e60882","volume":"161","author":"FX Rwandamuriye","year":"2020","unstructured":"Rwandamuriye FX, Weston BJ, Johns TG, Lesterhuis WJ, Zemek RM. A mouse model of incompletely resected soft tissue sarcoma for testing (Neo)adjuvant therapies. J Vis Exp. 2020;161(161):e60882.","journal-title":"J Vis Exp"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04300-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04300-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04300-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:29:03Z","timestamp":1778671743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04300-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4300"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04300-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed according to the guidelines of the Laboratory Program of the Animal Care and Use Committee of Huazhong University of Science and Technology (IACUC Number: 4141).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"435"}}